Loading Nifty 50, Nifty Bank, and Sensex…
Rubicon Research Limited
RUBICON · Corporate filings
NSE
Rubicon Research Limited
RUBICON · NSE · Healthcare
₹1,717.30
-0.35%
As of 12 Nov 2026
Rubicon Research Limited (RUBICON) is listed on NSE in the Healthcare sector. It last traded at ₹1,717.30, down 0.35% on the session. Its 52-week range is ₹609.25 to ₹1,899.00.
Research output is rule-based and informational only. It is not investment advice.
Analytics for RUBICON are not available yet. Technicals, fundamentals, peer ranking
and risk notes appear here once this listing's daily history and annual filings are synced.
Financial Charts & Report
Stock market charts for Rubicon Research Limited quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns stock, sector, and exchange benchmarks
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
Corporate Governance SEBI integrated governance filing
Loading governance disclosure...
Announcements
Announcement
Announcement
Announcement
Announcement
Announcement
Announcement
Announcement
Announcement
Announcement
Announcement
Announcement
Announcement
Insider trading
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Full history
Dividend
Dividend - Rs 1.50 Per Share Dividend - Rs 1.50 Per Share
Ex-date: 07 Aug 2026
Board Meetings
05 Nov 2026
Rubicon Research Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
14 Aug 2026
Rubicon Research Limited has submitted to the Exchange, the financial results for the quarter ended Jun 30, 2026.
20 Jul 2026
Rubicon Research Limited has informed the Exchange regarding Outcome of Board Meeting held on July 20, 2026.1. Date of 27th Annual General Meeting and Record Date for payment of final dividend on equity shares for the financial year 2025-26.2. Update on the merger of Kia Health Tech Private Limited, WOS, with Rubicon Research Limited
29 May 2026
Formulation, adoption and implementation of Rubicon Research Limited - Employees Stock Option Scheme 2026
29 May 2026
Rubicon Research Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.